China's Hanergy undone in a few minutes of frantic trading HONG KONG, May 23- Not long after Hanergy Thin Film Power Group began its annual shareholder meeting at a plush Hong Kong hotel this week, the Chinese solar company's shares went into free fall. Once the meeting was under way, several massive sell orders involving millions of shares overwhelmed the market, according to an analysis of Thomson Reuters trade log data.
| By: Elzio Barreto and Saikat Chatterjee
BlackBerry cuts jobs worldwide as it consolidates businesses May 22- Canadian smartphone maker BlackBerry Ltd is cutting jobs across the world, the company said on Friday, as it consolidates its software, hardware and applications business. The Waterloo, Ontario- based company last month said it was considering closing its offices in Sweden, a move that would result in the loss of up to 100 jobs. Up to Friday's close, the...
Former CEO's lawsuit against Sands China stays in Nevada LAS VEGAS- A Nevada judge has decided a wrongful termination case against Macau- based Sands China Ltd. and Sands Chairman Sheldon Adelson can stay in Nevada largely because of the influence Adelson wielded over the company, often from several thousand miles away. Clark County District Court Judge Elizabeth Gonzalez issued her ruling Friday afternoon after...
Source: The Associated Press
UPDATE 2-Amgen ends partnership with AstraZeneca on psoriasis drug May 22- Amgen Inc said it will terminate a collaboration with AstraZeneca Plc to develop a psoriasis drug after it observed suicidal thoughts in the subjects of a trial. AstraZeneca could decide on the development and marketing of the drug for all territories, except for Japan and certain Asian territories, where Kyowa Hakko Kirin has the rights to it, Amgen said.
| By: Amrutha Penumudi
These 7 stocks are like giant piggy banks If you like cash, you'll love seven stocks in the S&P 500 where cash and investments account for 40% or more of their stock prices, USA Today reports.
Source: USA Today
| By: Matt Krantz
UPDATE 1-Amgen ends partnership with AstraZeneca on inflammation drug May 22- Amgen Inc said it will terminate a collaboration with AstraZeneca Plc to develop an inflammation drug after it observed suicidal thoughts in the subjects of a trial. AstraZeneca could decide on the development and marketing of the drug for all territories, except for Japan and certain Asian territories, where Kyowa Hakko Kirin has the rights to it, Amgen...